American Healthcare REIT

AHRNYSEUSD

THESIS ALERT

Email me when the AHR thesis changes

Evidence-based analysis, not personalized investment advice. Every alert email carries an unsubscribe link.

Follow on X
$59.23
−$0.16 (−0.27%)Today 1M +16.91%
After hours$59.17−0.10%

Updated Nov 11, 4:00 PM ET · Regular session · May be delayed

Source valuation snapshot. Not a live recalculation.
Latest filed annual earnings; price snapshot date unavailable. Not forward P/E.
Diluted earnings per share from the latest filed annual.
$59.39
Prior regular-session close from the quote source.
$59.05–$59.55
Regular-session low and high so far today.
2.9M
Regular-session shares traded · Nov 11, 4:00 PM ET.
Feb 25 projected
Projected for 2027-02-25 from the company’s own results filings (SEC 8-K Item 2.02). The company has not confirmed the date.
$44.81–$59.55
52-week trading low and high returned by the quote source.

Understand the Business

Why the Stock Moved

Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.

The core investment thesis

Own AHR if AHR is a levered bet that its self-managed healthcare real estate platform can capture senior-housing upside fast enough to justify a valuation that already assumes durable growth.

AHR price history

Latest price$59.23Today−$0.16 (-0.27%)
AHR +13.54%S&P 500 -2.42%Since first plotted close
4 hours

Loading recent earnings…

Investment thesis

What must happen next

5 MATERIAL PROPOSITIONS
  • Needs-based demand for senior housing, integrated senior health campuses and clinical healthcare real estate continues to convert into AHR occupancy and pricing power rather than being displaced by home-based care or local oversupply.StrengtheningMateriality: High

    FY2025 annual GAAP revenue was $2.260 billion, up from $2.071 billion in FY2024 and $1.867 billion in FY2023. If this demand engine holds, AHR can keep expanding the revenue base; if it breaks, the premium growth story becomes ordinary real estate ownership.

    Watch: Large new senior-housing supply from Welltower, Ventas or local developers in AHR markets absorbs demand before AHR can raise occupancy or rates.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    FY2025 annual GAAP revenue was $2.260 billion, up from $2.071 billion in FY2024 and $1.867 billion in FY2023.

    Open source ↗
  • The RIDEA and self-managed operating model lets AHR capture senior-housing upside through operating leverage, provided labor and care-cost inflation do not consume the occupancy and rate gains.StrengtheningMateriality: High

    FY2025 annual GAAP operating income was $415.2 million, up from $363.5 million in FY2024 and $306.8 million in FY2023. This determines whether growth creates higher owner earnings or merely passes through higher operating costs.

    Watch: Nurse and caregiver shortages force sustained wage increases or agency labor usage across AHR’s senior housing and skilled nursing portfolio.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    FY2025 annual GAAP operating income was $415.2 million, up from $363.5 million in FY2024 and $306.8 million in FY2023.

    Open source ↗
  • AHR’s diversified current-income healthcare real estate portfolio continues to produce recurring operating cash flow despite exposure to operating healthcare assets.StrengtheningMateriality: Medium

    FY2025 annual GAAP operating cash flow was $294.4 million, up from $176.1 million in FY2024 and $98.5 million in FY2023. REIT value ultimately depends on distributable cash; if cash conversion weakens, earnings growth is less valuable to shareholders.

    Watch: Tenant or operator distress in skilled nursing causes rent deferrals, restructurings or higher working-capital needs.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    FY2025 annual GAAP operating cash flow was $294.4 million, up from $176.1 million in FY2024 and $98.5 million in FY2023.

    Open source ↗
  • The NYSE listing and larger equity base give AHR an acquisition and development currency, but external growth only creates value if assets can be bought or built above AHR’s cost of capital.StrengtheningMateriality: Medium

    AHR raised $772.8 million of gross proceeds in its February 2024 public offering and listed on the NYSE. If external growth is accretive, AHR can compound portfolio value; if capital becomes expensive or acquisitions are overpriced, growth dilutes owners.

    Watch: Healthcare real estate cap rates fall below AHR’s equity and debt cost, making acquisitions dilutive.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    AHR raised $772.8 million of gross proceeds in its February 2024 public offering and listed on the NYSE.

    Open source ↗
  • AHR’s balance sheet remains flexible enough that interest costs, refinancing needs and debt maturities do not crowd out investment or distributions.StrengtheningMateriality: Medium

    Liabilities declined to $2.066 billion at FY2025 year-end from $2.184 billion at FY2024 year-end and $3.119 billion at FY2023 year-end. Healthcare REITs need capital access; if leverage or rates tighten the model, property growth will not translate into per-share value.

    Watch: A credit-market shutdown prevents AHR from refinancing healthcare real estate debt on economic terms.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Liabilities declined to $2.066 billion at FY2025 year-end from $2.184 billion at FY2024 year-end and $3.119 billion at FY2023 year-end.

    Open source ↗
Full investment case & evidence

Loading the original research archive…

Original research

Needs-based demand for senior housing, integrated senior health campuses and clinical healthcare real estate continues to convert into AHR occupancy and pricing power rather than being displaced by home-based care or local oversupply. If this demand engine holds, AHR can keep expanding the revenue base; if it breaks, the premium growth story becomes ordinary real estate ownership.

The RIDEA and self-managed operating model lets AHR capture senior-housing upside through operating leverage, provided labor and care-cost inflation do not consume the occupancy and rate gains. This determines whether growth creates higher owner earnings or merely passes through higher operating costs.

AHR’s diversified current-income healthcare real estate portfolio continues to produce recurring operating cash flow despite exposure to operating healthcare assets. REIT value ultimately depends on distributable cash; if cash conversion weakens, earnings growth is less valuable to shareholders.

The NYSE listing and larger equity base give AHR an acquisition and development currency, but external growth only creates value if assets can be bought or built above AHR’s cost of capital. If external growth is accretive, AHR can compound portfolio value; if capital becomes expensive or acquisitions are overpriced, growth dilutes owners.

AHR’s balance sheet remains flexible enough that interest costs, refinancing needs and debt maturities do not crowd out investment or distributions. Healthcare REITs need capital access; if leverage or rates tighten the model, property growth will not translate into per-share value.

All standing thesis claims
Original report summary

AHR is a levered bet that its self-managed healthcare real estate platform can capture senior-housing upside fast enough to justify a valuation that already assumes durable growth.

Evidence assessed Nov 12, 2026. Expand each conclusion for its evidence and what would change it. Thesis evidence—not a buy or sell recommendation.

Bull case and bear case

Bull case and bear case for American Healthcare REIT

Where the evidence on American Healthcare REIT stands: Strengthening on the latest evidence (Nov 12, 2026). Of its 5 thesis points, 5 strengthening.

Bull case: what the evidence supports

  • Needs-based demand for senior housing, integrated senior health campuses and clinical healthcare real estate continues to convert into AHR occupancy and pricing power rather than being displaced by home-based care or local oversupply.

    sec.gov ↗

  • The RIDEA and self-managed operating model lets AHR capture senior-housing upside through operating leverage, provided labor and care-cost inflation do not consume the occupancy and rate gains.

    sec.gov ↗

  • AHR’s diversified current-income healthcare real estate portfolio continues to produce recurring operating cash flow despite exposure to operating healthcare assets.

    sec.gov ↗

  • The NYSE listing and larger equity base give AHR an acquisition and development currency, but external growth only creates value if assets can be bought or built above AHR’s cost of capital.

    sec.gov ↗

  • AHR’s balance sheet remains flexible enough that interest costs, refinancing needs and debt maturities do not crowd out investment or distributions.

    sec.gov ↗

Bear case: what would count against it

  • Large new senior-housing supply from Welltower, Ventas or local developers in AHR markets absorbs demand before AHR can raise occupancy or rates.

    sec.gov ↗

  • Nurse and caregiver shortages force sustained wage increases or agency labor usage across AHR’s senior housing and skilled nursing portfolio.

    sec.gov ↗

  • Tenant or operator distress in skilled nursing causes rent deferrals, restructurings or higher working-capital needs.

    sec.gov ↗

Thesis-Break Engine

What has broken in American Healthcare REIT’s thesis

Each break OptimistFi flagged on American Healthcare REIT, dated — with what has historically followed the same kind of break across the market, not a forecast for American Healthcare REIT.

peers+15%-20%-2%12 mo agonow+6 mo
Daily price, then where similar breaks led across the market: the typical -2% path vs comparable companies over six months, inside the middle-half range (+15% to -20%). A base rate, not a forecast.
  • CEO / officer changecondition set before this filing

    Across all companies, this kind of break has happened 16,849 times before. Those stocks trailed comparable companies by a median of 2% over the next six months, and 38% of them trailed it by 10 points or more.

How the Thesis-Break Engine works →Historical outcomes are measured against comparable companies after past breaks of the same kind, across all companies. Not a prediction.

MARKET + FINANCIAL SNAPSHOT

The numbers behind the thesis

Sourced from filings and market data

What Changed

  1. Mixed
    Entered a material definitive agreement.

    American Healthcare REIT filed an SEC 8-K on 2026-11-06: Entered a material definitive agreement. It is a dated development that tests the current thesis.

  2. Mixed
    Reported results of operations (earnings release).

    American Healthcare REIT filed an SEC 8-K on 2026-11-05: Reported results of operations (earnings release). It is a dated development that tests the current thesis.

  3. Mixed
    Regulation FD disclosure.

    American Healthcare REIT filed an SEC 8-K on 2026-09-18: Regulation FD disclosure. It is a dated development that tests the current thesis.

Risks / falsifiers

What could break the thesis

  • Large new senior-housing supply from Welltower, Ventas or local developers in AHR markets absorbs demand before AHR can raise occupancy or rates.
  • Nurse and caregiver shortages force sustained wage increases or agency labor usage across AHR’s senior housing and skilled nursing portfolio.
  • Tenant or operator distress in skilled nursing causes rent deferrals, restructurings or higher working-capital needs.
  • Healthcare real estate cap rates fall below AHR’s equity and debt cost, making acquisitions dilutive.
  • A credit-market shutdown prevents AHR from refinancing healthcare real estate debt on economic terms.

AHR news

Loading headlines…

Financial statements

AHR income statement

Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.

AHR: quick answers

When does American Healthcare REIT (AHR) report earnings next?
American Healthcare REIT's next results are projected for February 25, 2027, from the dates of its own results filings with the SEC. The company has not confirmed the date. It last reported on November 5, 2026. Earnings calendar
What is AHR's short interest?
As of October 30, 2026, 33.7M AHR shares were sold short, 14.5% of its shares outstanding, up 1.5% from the count before. At the stock's average daily volume that is 10 days to cover. FINRA publishes the count twice a month. AHR short interest history
Which well-known investors own AHR?
1 of the 37 well-known funds tracked here reported AHR shares in their latest 13F filing. By share of the fund's portfolio: Soros Fund Management (George Soros), 0.3%. Fund portfolios

AHR in well-known investors’ portfolios

1 of 37 funds reported AHR shares in their latest 13F filing. A 13F shows quarter-end positions and arrives up to 45 days later.

FundOf its portfolioValueChangeQuarter
George SorosSoros Fund Management0.27%$22.4MNewQ2 2026

Every fund’s portfolio

ScoutJUST THIS STORY

LET’S MAKE THIS USEFUL · 1 OF 5

How would you like me to explain this?

Tell me what you want from this read. Start with a quick note, then adjust the details. Your other stories stay as they are.

We’ll remember your view of this story. The published article stays unchanged.

THIS STORY’S READING VIEWStandard · The whole picture

Clear explanations with context. Both sides of the evidence.